Product Program year 2025 Source: CMS Open Payments

Oes Cystonephrofiberscope

Device Urology Gynecology

PDI 04953170411144

Open in the dashboard

General payments

$214,925

523 payments

Research payments

$0

0 payments

Through program year 2025, $214,925 in general payments and $0 in research payments were reported against Oes Cystonephrofiberscope (Urology Gynecology).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

5 rows
Year Kind Amount Payments
2025 General $50,321 166
2024 General $43,009 123
2023 General $52,109 149
2022 General $18,665 39
2021 General $50,822 46

Breakdown

Who paid General payments · program years 2021–2025
  1. Olympus Corporation of the Americas $126,028 408 payments
  2. Olympus America Inc. $86,008 112 payments
  3. Olympus Winter & Ibe GmbH $2,160 2 payments
  4. Gyrus ACMI, Inc. $730 1 payment
Top recipients General payments · program year 2025
  1. Joshua Meeks Urology · Chicago, IL $11,905 24% · 19 payments
  2. Bernard Bochner Urology · New York, NY $10,491 21% · 14 payments
  3. John Sfakianos Urology · New York, NY $7,303 15% · 14 payments
  4. Deepak Kapoor Urology · Bethpage, NY $5,212 10% · 1 payment
  5. Farhad Nowzari Urology · Torrance, CA $4,828 10% · 1 payment

The top 5 of 32 recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Urology $47,512 100% · 24 practitioners
  2. Nurse Practitioner, Family Nurse Practitioner $66 <1% · 2 practitioners

Each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

Where the money went General payments · program year 2025
  1. New York $26,006 52% · 7 recipients
  2. Illinois $12,633 25% · 3 recipients
  3. California $6,394 13% · 3 recipients
  4. Missouri $1,698 3% · 3 recipients
  5. Texas $839 2% · 1 recipient

The top 5 of 14 states; each share is of general payments naming this product in 2025 where a state was reported.

The top 25 states, free in the app

523 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record